Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Stem Cell and 3D Printing Generate Viable Tissue

By LabMedica International staff writers
Posted on 11 May 2017
A team of Swedish cell biologists combined three-dimensional (3D) bio-printing with advanced stem cell technology to create viable cultures of cartilage tissue that had cellular and mechanical properties similar to patients’ natural cartilage.

Cartilage lesions can progress into secondary osteoarthritis and cause severe clinical problems in numerous patients. More...
To fill and cure such lesions, investigators at the University of Gothenburg developed a novel class of stem cells that could survive being injected by a three-dimensional printing method and then mature into functional cartilage tissue.

The investigators began with cartilage cells taken from patients undergoing knee surgery. These cells were then manipulated in a laboratory and transformed into induced pluripotent stem cells. The stem cells were expanded and encapsulated in a solution of nanofibrillated cellulose and printed into a structure using a three-dimensional (3D) bio-printer. Following printing, the stem cells were treated with growth factors that caused them to differentiate into cartilage tissue.

Much of the research effort involved finding a procedure to enable the cells to survive printing and multiply and a protocol that induced the cells to differentiate to form cartilage.

Results published in the April 6, 2017, online edition of the journal Scientific Reports revealed that pluripotency was initially maintained, and after five weeks, hyaline-like cartilaginous tissue with collagen type II expression and lacking tumorigenic Oct4 expression was observed in the three-dimensional (3D)-bio-printed constructs. Moreover, a marked increase in cell number within the cartilaginous tissue was detected by 2-photon fluorescence microscopy, indicating the importance of high cell densities in the pursuit of achieving good survival after printing.

“In nature, the differentiation of stem cells into cartilage is a simple process, but it is much more complicated to accomplish in a test tube. We are the first to succeed with it, and we did so without any animal testing whatsoever," said senior author Dr. Stina Simonsson, associate professor of cell biology at the University of Gothenburg. "We investigated various methods and combined different growth factors. Each individual stem cell is encased in nanocellulose, which allows it to survive the process of being printed into a three-dimensional (3D) structure. We also harvested media from other cells that contain the signals that stem cells use to communicate with each other - so called conditioned medium. In layman’s terms, our theory is that we managed to trick the cells into thinking that they are not alone.”


Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Blood Glucose Reference Analyzer
Nova Primary
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.